Gemizan 1gm Injection
By Gemizan
Rx
1 Injection in a Vial

Composition
Gemcitabine(1gm)

Manufacturer - Zuventus Healthcare Ltd
Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (E), Mumbai - 400 072.

Expires on or after
April, 2026

liver
Caution should be taken when using Gemizan 1gm Injection in patients with liver disease. It is advisable to consult your doctor before starting treatment with this medication as there is limited information available regarding its use in individuals with liver issues. Your doctor will be able to provide guidance tailored to your specific situation.

kidney
Limited data exists on using Gemizan 1gm Injection in kidney disease. Prior consultation with a doctor is crucial. Kidney function tests before and during treatment are advised for safety. Regular monitoring post-treatment is also recommended.

alcohol
Gemizan 1gm Injection can increase drowsiness when taken with alcohol. This can be dangerous, so avoid alcohol while using this medication. Additionally, please be cautious if you are pregnant.

driving
Do not drive if Gemizan 1gm Injection causes drowsiness, reduced alertness, or vision problems.

pregnancy
Gemizan 1gm Injection is not recommended during pregnancy due to potential risk to the baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before using.

breastfeeding
Gemizan 1gm Injection is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Cytosine Analogue |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Antimetabolites |
₹6587.62
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024